Clinical Trials Directory

Trials / Completed

CompletedNCT01796587

Non-Interventional Study Among Users Of LoFric Origo

Status
Completed
Phase
Study type
Observational
Enrollment
423 (actual)
Sponsor
Wellspect HealthCare · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary objective: To evaluate compliance of LoFric Origo in a general intermittent catheterization (IC) population with the use of LoFric Origo, by means of a subjective assessment scale Secondary objectives: * To evaluate the subject's perception associated with the use of the LoFric Origo, by means of a subjective assessment scale * To evaluate the subject's discomfort associated with the use of the LoFric Origo, by means of a subjective assessment scale * To observe and collect data on bladder regimen/IC frequency by assessments of descriptive data of demography, catheter therapy, history and other patient reported outcomes. Study Design: Non-interventional study, multicentre, prospective study. Target Subject Population: General intermittent catheterization, LoFric Origo male users. Medical Device: LoFric Origo Study Variable(s): * Primary variable: Use or No use of LoFric Origo after 8 weeks. * Secondary variable(s): patient reported questionnaire with regards to perception, discomfort, diagnose, health status, catheter history and other patient reported outcomes.

Conditions

Interventions

TypeNameDescription
DEVICELoFric Origo

Timeline

Start date
2013-01-01
Primary completion
2015-03-01
First posted
2013-02-22
Last updated
2015-05-08

Locations

19 sites across 6 countries: Belgium, France, Netherlands, Norway, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT01796587. Inclusion in this directory is not an endorsement.